White coat hypertension in acute retinal vein occlusion

TL;DR

This study explores the link between white coat hypertension and acute retinal vein occlusion, finding a higher occurrence in affected patients.

Contribution

The study identifies a novel association between white coat hypertension and acute retinal vein occlusion, particularly in untreated patients.

Findings

The RVO group had a significantly higher proportion of white coat hypertension and sustained hypertension compared to the non-RVO group.

In untreated patients, the RVO group still showed a higher proportion of white coat hypertension or sustained hypertension.

Interventions for white coat hypertension remain unstandardized, suggesting a need for further research.

Abstract

To investigate the association between white-coat hypertension (WCH) and acute retinal vein occlusion (RVO).

In this retrospective case-control study, patients aged 40 years or older diagnosed with acute-phase RVO were included. Patients with other pathologies served as non-RVO controls. Blood pressure (BP) was measured in the office during their initial visit, and information about home BP and hypertension (HTN) medication was obtained through interviews. After 1:2 age and sex-matching between the RVO and non-RVO groups, the proportions of HTN cases were compared. A similar comparison was made in subgroups with or without HTN medication.

Fifty-one patients with RVO and 102 with non-RVO were included in the analysis. For the entire cohort, the RVO group exhibited a significantly greater proportion of WCH and sustained HTN compared to the non-RVO group. In the subgroup without HTN treatment, the proportion of WCH or sustained HTN was still significantly higher in the RVO group. However, in the subgroup receiving HTN treatment, the proportion of WCH or sustained HTN was higher in the RVO group than in the non-RVO group, though not statistically significant.

This case-control study suggests that WCH may be associated with RVO, particularly in patients without HTN treatment. Given that interventions for WCH have not been standardized, a more detailed and prospective study is warranted to elucidate the risk of WCH for RVO and other retinal vascular diseases.

Figures